146 related articles for article (PubMed ID: 37822530)
1. Development and External Validation of a Nomogram for Predicting the Effect of RTX on the Treatment of Membranous Nephropathy.
Guo Y; Ren M; Pang X; Wang Y; Yu L; Tang L
J Inflamm Res; 2023; 16():4399-4411. PubMed ID: 37822530
[TBL] [Abstract][Full Text] [Related]
2. PLA2R-IgG4 antibody as a predictive biomarker of treatment effectiveness and prognostic evaluation in patients with idiopathic membranous nephropathy: a retrospective study.
Huang Y; Zhou J; Zhou K; Huang B; Xue J; Zhang X; Liu B; Zhang Z; Zhou L; Cai T; Zhang Y; Hu Z; Wang L; Liu X
PeerJ; 2022; 10():e14193. PubMed ID: 36248712
[TBL] [Abstract][Full Text] [Related]
3. Rituximab in patients with membranous nephropathy and kidney insufficiency.
Guo Y; Wang L; Wang Y; Li X; Zhai Z; Yu L; Liang Y; Liu P; Tang L
Front Pharmacol; 2022; 13():1002117. PubMed ID: 36299887
[No Abstract] [Full Text] [Related]
4. Rituximab in Patients With Phospholipase A2 Receptor-Associated Membranous Nephropathy and Severe CKD.
Hanset N; Esteve E; Plaisier E; Johanet C; Michel PA; Boffa JJ; Fievet P; Mesnard L; Morelle J; Ronco P; Dahan K
Kidney Int Rep; 2020 Mar; 5(3):331-338. PubMed ID: 32154454
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rituximab for primary membranous nephropathy with different clinical presentations: a retrospective study.
Zhang S; Huang J; Dong J; Li Z; Sun M; Sun Y; Chen B
Front Immunol; 2023; 14():1156470. PubMed ID: 37187749
[TBL] [Abstract][Full Text] [Related]
6. Low-dose rituximab is poorly effective in patients with primary membranous nephropathy.
Moroni G; Depetri F; Del Vecchio L; Gallelli B; Raffiotta F; Giglio E; Brunini F; D'Amico M; Longhi S; Radice A; Messa P; Sinico RA
Nephrol Dial Transplant; 2017 Oct; 32(10):1691-1696. PubMed ID: 27387472
[TBL] [Abstract][Full Text] [Related]
7. Machine learning model to estimate probability of remission in patients with idiopathic membranous nephropathy.
Duo L; Chen L; Zuo Y; Guo J; He M; Zhao H; Kang Y; Tang W
Int Immunopharmacol; 2023 Dec; 125(Pt A):111126. PubMed ID: 37913570
[TBL] [Abstract][Full Text] [Related]
8. [A novel approach to rapid induction of remission in primary membranous nephropathy].
Dobronravov VA; Bystrova OB; Kochoyan ZS; Fomicheva EN
Ter Arkh; 2021 Jun; 93(6):706-712. PubMed ID: 36286838
[TBL] [Abstract][Full Text] [Related]
9. A preliminary nomogram model for predicting relapse of patients with primary membranous nephropathy.
Li M; Wang H; Lai X; Guo D; Jiang C; Fu Z; Liu X
Ren Fail; 2023 Dec; 45(1):2199092. PubMed ID: 37038751
[TBL] [Abstract][Full Text] [Related]
10. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures.
Li Q; Long X; Wang Y; Fang X; Guo D; Lv J; Hu X; Cai L
BMC Musculoskelet Disord; 2021 Nov; 22(1):957. PubMed ID: 34784910
[TBL] [Abstract][Full Text] [Related]
12. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rituximab in the treatment of membranous nephropathy: A systematic review and meta-analysis.
Lu W; Gong S; Li J; Luo H; Wang Y
Medicine (Baltimore); 2020 Apr; 99(16):e19804. PubMed ID: 32311997
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Risk Nomogram Model for Predicting Constipation in Patients with Type 2 Diabetes Mellitus.
Yuan HL; Zhang X; Peng DZ; Lin GB; Li HH; Li FX; Lu JJ; Chu WW
Diabetes Metab Syndr Obes; 2023; 16():1109-1120. PubMed ID: 37114216
[TBL] [Abstract][Full Text] [Related]
15. [Risk factor analysis on body mass rebound after laparoscopic sleeve gastrectomy and establishment of a nomogram prediction model].
Zhao J; Jiao YW; Qian J; Qian ZF; Yang HJ; Tang LM
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Oct; 25(10):913-920. PubMed ID: 36245117
[No Abstract] [Full Text] [Related]
16. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
17. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.
Li W; Xiao Y; Xu X; Zhang Y
Ann Surg Oncol; 2021 Jul; 28(7):3490-3500. PubMed ID: 33191484
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
[TBL] [Abstract][Full Text] [Related]
19. [Clinical value of nomogram model in evaluating the prognosis of cholangiocarcinoma after interventional therapy].
Li Z; Xie BC; Lyu PJ; Wang HX; Li Y; Wang CH; Li X; Ye SW; Li G; Pang PF; Zhang YY; Yu P
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1217-1224. PubMed ID: 37087405
[No Abstract] [Full Text] [Related]
20. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.
Zhan G; Peng H; Zhou L; Jin L; Xie X; He Y; Wang X; Du Z; Cao P
Front Endocrinol (Lausanne); 2023; 14():1070396. PubMed ID: 36798659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
